SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1244Marc - As always - your fact finding and subsequent synopsis is TOPS .... John McCarthy-11/13/2003
1243testJMarcus-11/12/2003
1242John, you suggested that at tomorrow's stockholders meeting I should ask PauJMarcus-11/12/2003
1241John, At the annual meeting 2 years ago (I think), I asked Paul F. about determlrb-10/27/2003
1240Neuropathic pain royalty rates. One of the thorniest but extremely important issDr. John M. de Castro-10/27/2003
1239Thanks, John, that must be it.tom pope-10/23/2003
1238tom - just guessing here .... I think what was expected was a approvable decisJohn McCarthy-10/23/2003
1237<i>In an unexpected move</i> unexpected???tom pope-10/22/2003
1236JM Dutton Note issued 10/21... jmdutton.comWilliam F. Wager, Jr.-10/22/2003
1235Forest Laboratories to Resume Clinical Development of Neuropathic Pain Indicatiolrb-10/22/2003
1234Alzheimer's Association Encouraged by FDA Approval of Memantine 1sim1-10/18/2003
1233John, your info is so much appreciated. When we get closer to the date of the sJMarcus-10/17/2003
1232Marc - I am under the impression that the following is true ... (1) IrrespectiJohn McCarthy-10/17/2003
1231Neurobiological Technologies, Inc. (NTI(R)) Announces That Forest Laboratories, JMarcus-10/17/2003
1230If the analysis of the data suggested (to a fair minded scientist) that changes JMarcus-10/17/2003
1229Hi Marc - just an add-on to your note .... [per person on Yahoo board who listJohn McCarthy-10/17/2003
1228Today the FDA approved memantine (new brand name, "Namenda") for the JMarcus-10/17/2003
1227This year's stockholders meeting (which I will again attend) is scheduled foJMarcus-10/16/2003
1226Alzheimer's Drug May Enter U.S. Market LAURAN NEERGAARD Associated Press Psim1-9/25/2003
1225GS Note: Forest Laboratories EPS (FY Mar) 2004E US$1.99, 2005E US$2.33 In-Line/Nmopgcw-9/24/2003
1224Marc - thanks! JohnJohn McCarthy-9/24/2003
1223John, I think congratulations (and many, many thanks from the readers of your twJMarcus-9/24/2003
1222Unanimous backing by the Advisory Committee. Sounds pretty good to me. Marc -JMarcus-9/24/2003
1221Neurobiological Technologies Buy Rating Issued In Update Initial Report; 12-Montmopgcw-9/22/2003
1220Smart Bombs - AUGUST 21, 2003 COVER STORY By Catherine Arnst "I Can&#John McCarthy-8/25/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News